| |
Recombinant Human Ad-p53 Injection
|
Mechanism of Action:
Gendicine is a gene therapy drug to treat malignant cancers. It is mainly composed of replication-incompetent recombinant Ad-p53 virus particles, which based on adenovirus serotype ... |
Shenzhen SiBiono GeneTech Co., Ltd. |